Rab A, Rowe SM, Raju SV, Bebok Z, Matalon S, Collawn JF
2011;6:e22400
Cycle Guidelines Common NAD+ Cycle Reference Approach Standard SubQ Duration 4-8 weeks Review point Week 4 Best for General research-context cellular-energy planning Approach Extended SubQ + oral bridge Duration 8-12 weeks SubQ, then 4 weeks oral NMN/NR Review point End of injectable phase Best for Layered approach combining injection and oral precursors Approach IV maintenance Duration Weekly or bi-weekly, ongoing Review point Every 4-8 weeks Best for Clinic-supervised research planning Approach IV loading + maintenance Duration 3-5 daily IV sessions, then weekly/monthly Review point After loading phase Best for Intensive clinic protocol Unlike receptor-based peptides, NAD+ is a coenzyme
Shipping speed is a recurring criticism, but the general consensus is that the quality justifies the wait
Converting between formulations and products If you switch pharmacies, switch from compounded to brand-name tirzepatide, or switch from semaglutide to tirzepatide, the dose conversion requires attention
The usual adult dosage is 1 ampoule daily for 5 days or as directed by a physician
